Quiz 2 Review Flashcards
- Regarding the tri nucleotide repeat associated with Huntington’s disease, it is
a. CAG repeat that occurs in the 3/ untranslated region?
b. CAG repeat that occurs in the intron
c. CAG repeat that occurs in the exon
d. CAG repeat that occurs in the 5’ untranslated region
e. CAG repeat that occurs in the promoter
c. CAG repeat that occurs in the exon
- Which of the following complexes of the respritory chain does not contain a subunit encoded by mitochondrial DNA? Complex 1
a. Complex 2
b. Complex3
c. Complex4
d. Complex 5
a. Complex 2
- A couple both have achondroplasia. They are the only affected individuals in their respective families. The woman is currently pregnant. What is the chance that the fetus has a lethal form of achondroplasia.
a. 0
b. 25%
c. 50%
d. 75%
e. 100%
b. 25%
- in your pt with amelogenesia imperfect, a laboratory identified the mutation p. Trp153* What does this indicate?
a. A stop codon was eliminated
b. A stop codon was created
c. An amino acid substitution occurred
d. An alteration was fond at nucleotide 153
e. None of the above
b. A stop codon was created
- Your pt has the following mutation c200+IG>A what does this mean
a. A deletion has occurred
b. A missense mutation has occurred
c. A nonsense mutation has occurred
d. A splicing mutation has occurred
e. An insertion has occurred
d. A splicing mutation has occurred
- A woman is a carrier for sickle cell anemia. Her husband is not a carrier and does not have sickle cell anemia. If their child has sickle cell anemia, what is the most likely explanation
a. A maternal meiosis 1 error occurred
b. A maternal meiosis 2 error occurred
c. A paternal meiosis 1 error occurred
d. A paternal meiosis 2 error occurred
e. The lady is a tramp
b. A maternal meiosis 2 error occurred
- Fragile X syndrome is due to a CGG expansion in the 5’ UTR of the FMR1 gene. Affected individuals have over 200 repeats. When the repeats reach this size or larger, the promoter is modified so that no RNA is produced. What is this modification
a. Phosphorylation
b. Acetylation
c. Glycosylation
d. Methylation
e. Hydroxylation
d. Methylation
- Which of the following is NOT a usual mechanism of diseases for autosomal dominant disorders?
a. Dominant negative
b. Gain of function
c. Haploinsufficiency
d. Loss of function
d. Loss of function
- Type 1 osteogenesis imperfect WITHOUT dentinogenesis imperfect is due to what molecular mechanism
a. Loss of function
b. Gain of function
c. Haploinsufficiency
d. Dominant negative
e. None of the above
c. Haploinsufficiency
- Which term describes a disorder like cystic fibrosis where many different mutations give the same clinical phenotype?
a. Clinical heterogencity
b. Genetic heterogencity
c. Allele heterogencity
d. Locus heterogencity
c. Allele heterogencity
Fragile X ?
-CGG repeat in 5’ UTR noncoding
- X-linked
- > 200 DOSE load required
- Methylate promoter
- USE SOUTHERN BLOT
- Pre-muation carriers
- Male ATAXIA
- Repeats don’t expand if passed on by MALE
Huntington’s Disease
- Autosomal Dominant
- CAG in exon
- Polyglutamine disorder(repeat expansion smaller in size & variation)
- -small repeat so PCR
-40 REPEATS & live long enough= magic number for HD
**Toxic GAIN of FUNCTION
-Characterized by progressive neuronal dysfunction that begins in mid-life, resulting in severe neurodegenration
Friedrich Ataxia?
- Autosomal RECESSIVE
- Intron
-GAA repeat in intron
(Trinucleotide repeat disorder)
Mytotonic Dystrophy
What kind of repeat?
Clinical findings?
Diagnosis?
-Autosomal Dominant
- CTG repeat
- 3’ region
- non coding repeat
- Clinical finding categorized into 3 phenotypes: 1) mild 2) classical 3) congenital
Diagnosis:
-Adults = muscle weakness (distal leg), hand, neck & face. Sustained muscle contraction and cataracts
-Neonates= Club foot, respiratory insufficiently or failure, generalized weakness, facial muscle weakness, & hypotonia.
Achondroplasia?
-Inheritance?
Inheritance:
- Autosomal Dominant
- Incomplete dominance
- Homozygous from LETHAL
- **PATERNAL Single Locus Mutation